Published in Infect Immun on February 01, 2000
In vivo imaging of transgenic Leishmania parasites in a live host. J Vis Exp (2010) 1.13
Heterologous expression of Trypanosoma cruzi trans-sialidase in Leishmania major enhances virulence. Infect Immun (2000) 0.94
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol (1989) 31.72
The regulation of immunity to Leishmania major. Annu Rev Immunol (1995) 8.05
A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol (1985) 4.71
Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med (1993) 4.49
Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J Immunol (1989) 4.44
Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression. Mol Cell Biol (1990) 4.13
Identification of an infective stage of Leishmania promastigotes. Science (1984) 4.00
Gene replacement in parasitic protozoa. Nature (1990) 3.15
Development of a stable Leishmania expression vector and application to the study of parasite surface antigen genes. Proc Natl Acad Sci U S A (1990) 2.52
Use of the green fluorescent protein as a marker in transfected Leishmania. Mol Biochem Parasitol (1996) 2.19
Immunology of leishmaniasis. Adv Parasitol (1993) 2.16
Infection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a non-parasite antigen. J Immunol (1992) 2.14
Development of a safe live Leishmania vaccine line by gene replacement. Proc Natl Acad Sci U S A (1995) 1.99
T-cell and cytokine responses in leishmaniasis. Curr Opin Immunol (1993) 1.92
Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis. Infect Immun (1983) 1.90
Leishmania tropica: pathogenicity and in vitro macrophage function in strains of inbred mice. Exp Parasitol (1979) 1.88
Plasticity in chromosome number and testing of essential genes in Leishmania by targeting. Proc Natl Acad Sci U S A (1993) 1.88
Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon. Clin Exp Immunol (1984) 1.51
Leishmania major interferes with antigen presentation by infected macrophages. J Immunol (1993) 1.35
Sand fly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production. J Immunol (1995) 1.28
Leishmania major and L. donovani: a method for rapid purification of amastigotes. Exp Parasitol (1990) 1.23
Cytokines in leishmaniasis: a complex network of stimulatory and inhibitory interactions. Immunobiology (1993) 1.17
Variants with reduced virulence derived from Leishmania major after mutagen treatment. Parasite Immunol (1987) 1.12
Leishmania major-parasitized macrophages augment Th2-type T cell activation. J Immunol (1994) 1.11
Interactions between Leishmania major and macrophages. Immunol Ser (1994) 1.03
Simultaneous transient expression assays of the trypanosomatid parasite Leishmania using beta-galactosidase and beta-glucuronidase as reporter enzymes. Gene (1991) 1.02
Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells specific for amastigote cysteine proteinases requires intracellular killing of the parasites. Eur J Immunol (1995) 1.02
T cell and non-T cell compartments can independently determine resistance to Leishmania major. J Exp Med (1995) 1.00
Leishmania major-specific, CD4+, major histocompatibility complex class II-restricted T cells derived in vitro from lymphoid tissues of naive mice. J Exp Med (1993) 0.98
Class II major histocompatibility complex-deficient mice initially control an infection with Leishmania major but succumb to the disease. J Infect Dis (1995) 0.96
Up-regulation of T helper 2 and down-regulation of T helper 1 cytokines during murine retrovirus-induced immunodeficiency syndrome enhances susceptibility of a resistant mouse strain to Leishmania amazonensis. Am J Pathol (1995) 0.94
Antigens targeted to the Leishmania phagolysosome are processed for CD4+ T cell recognition. Eur J Immunol (1993) 0.92
Leishmania mexicana promastigotes induce cytotoxic T lymphocytes in vivo that do not recognize infected macrophages. Eur J Immunol (1993) 0.90
Modulation of specific T cell responses by concurrent infection with Leishmania major and LP-BM5 murine leukemia viruses. Int Immunol (1995) 0.85
Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice. Exp Parasitol (1996) 0.82
A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol (1985) 4.71
Rapid duplication and loss of genes coding for the alpha chains of hemoglobin. Proc Natl Acad Sci U S A (1980) 4.33
Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression. Mol Cell Biol (1990) 4.13
Molecular evolution in Drosophila and the higher Diptera II. A time scale for fly evolution. J Mol Evol (1984) 3.98
Double targeted gene replacement for creating null mutants. Proc Natl Acad Sci U S A (1991) 3.72
Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J Immunol (1985) 3.47
Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science (1989) 3.25
Effect of maternal multiple micronutrient supplementation on fetal loss and infant death in Indonesia: a double-blind cluster-randomised trial. Lancet (2008) 3.22
Gene replacement in parasitic protozoa. Nature (1990) 3.15
Trans-kingdom transposition of the Drosophila element mariner within the protozoan Leishmania. Science (1997) 2.92
Coupling of poly(A) site selection and trans-splicing in Leishmania. Genes Dev (1993) 2.82
A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol (2001) 2.72
Adipocyte P2 gene: developmental expression and homology of 5'-flanking sequences among fat cell-specific genes. Proc Natl Acad Sci U S A (1986) 2.70
Overproduction of a bifunctional thymidylate synthetase-dihydrofolate reductase and DNA amplification in methotrexate-resistant Leishmania tropica. Proc Natl Acad Sci U S A (1983) 2.59
Development of a stable Leishmania expression vector and application to the study of parasite surface antigen genes. Proc Natl Acad Sci U S A (1990) 2.52
Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity. J Immunol (1984) 2.35
Unstable DNA amplifications in methotrexate-resistant Leishmania consist of extrachromosomal circles which relocalize during stabilization. Cell (1984) 2.28
Molecular assays for surveillance of antifolate-resistant malaria. Lancet (1998) 2.26
Use of the green fluorescent protein as a marker in transfected Leishmania. Mol Biochem Parasitol (1996) 2.19
Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc Natl Acad Sci U S A (2000) 2.11
Primary structure of the gene encoding the bifunctional dihydrofolate reductase-thymidylate synthase of Leishmania major. Proc Natl Acad Sci U S A (1986) 2.05
A set of independent selectable markers for transfection of the human malaria parasite Plasmodium falciparum. Proc Natl Acad Sci U S A (1999) 2.04
Development of a safe live Leishmania vaccine line by gene replacement. Proc Natl Acad Sci U S A (1995) 1.99
Plasticity in chromosome number and testing of essential genes in Leishmania by targeting. Proc Natl Acad Sci U S A (1993) 1.88
Novel DNA rearrangements are associated with dihydrofolate reductase gene amplification. J Biol Chem (1984) 1.86
Relationship of amplified dihydrofolate reductase genes to double minute chromosomes in unstably resistant mouse fibroblast cell lines. Mol Cell Biol (1981) 1.83
Evolution of the genus Leishmania as revealed by comparisons of nuclear DNA restriction fragment patterns. Proc Natl Acad Sci U S A (1987) 1.77
Regulation of differentiation to the infective stage of the protozoan parasite Leishmania major by tetrahydrobiopterin. Science (2001) 1.77
PTR1: a reductase mediating salvage of oxidized pteridines and methotrexate resistance in the protozoan parasite Leishmania major. Proc Natl Acad Sci U S A (1994) 1.76
Quality of life following radiofrequency ablation of dysplastic Barrett's esophagus. Endoscopy (2010) 1.75
Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infection. J Immunol (2001) 1.74
The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol (2000) 1.73
A bifunctional thymidylate synthetase-dihydrofolate reductase in protozoa. Mol Biochem Parasitol (1984) 1.71
Properties of an altered dihydrofolate reductase encoded by amplified genes in cultured mouse fibroblasts. J Biol Chem (1981) 1.71
The role of phosphoglycans in Leishmania-sand fly interactions. Proc Natl Acad Sci U S A (2000) 1.68
Evolution of nuclear ribosomal RNAs in kinetoplastid protozoa: perspectives on the age and origins of parasitism. Proc Natl Acad Sci U S A (1993) 1.62
A simple method for quantifying Leishmania in tissues of infected animals. Parasitol Today (1997) 1.61
Intergenic region typing (IRT): a rapid molecular approach to the characterization and evolution of Leishmania. Mol Biochem Parasitol (1995) 1.61
An OspC-specific monoclonal antibody passively protects mice from tick-transmitted infection by Borrelia burgdorferi B31. Infect Immun (1999) 1.60
Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution. Infect Immun (1990) 1.55
Heavy metal resistance: a new role for P-glycoproteins in Leishmania. J Biol Chem (1991) 1.55
Functional analysis of the steroid hormone control region of mouse mammary tumor virus. Nucleic Acids Res (1984) 1.54
Evidence that the vectorial competence of phlebotomine sand flies for different species of Leishmania is controlled by structural polymorphisms in the surface lipophosphoglycan. Proc Natl Acad Sci U S A (1994) 1.52
Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon. Clin Exp Immunol (1984) 1.51
Leishmania major: promastigotes induce expression of a subset of chemokine genes in murine macrophages. Exp Parasitol (1997) 1.51
Orally induced tolerance. Definition at the cellular level. Int Arch Allergy Appl Immunol (1981) 1.48
Analysis of enhancing effect of sand fly saliva on Leishmania infection in mice. Infect Immun (1991) 1.46
Demonstration of circularization of herpes simplex virus DNA following infection using pulsed field gel electrophoresis. Virology (1993) 1.46
Dual role of the fringe connection gene in both heparan sulphate and fringe-dependent signalling events. Nat Cell Biol (2001) 1.46
Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species. Trends Parasitol (2001) 1.45
A specialized pathway affecting virulence glycoconjugates of Leishmania. Science (1995) 1.45
Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice. J Immunol (1986) 1.45
Experimental syphilis in the rabbit: passive transfer of immunity with immunoglobulin G from immune serum. J Infect Dis (1979) 1.44
cis and trans factors affecting Mos1 mariner evolution and transposition in vitro, and its potential for functional genomics. Nucleic Acids Res (2000) 1.43
Golgi GDP-mannose uptake requires Leishmania LPG2. A member of a eukaryotic family of putative nucleotide-sugar transporters. J Biol Chem (1997) 1.43
Transcriptional mapping of the amplified region encoding the dihydrofolate reductase-thymidylate synthase of Leishmania major reveals a high density of transcripts, including overlapping and antisense RNAs. Mol Cell Biol (1989) 1.42
The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major. J Biol Chem (1997) 1.42
The immunomodulatory factors of bloodfeeding arthropod saliva. Parasite Immunol (2000) 1.42
Altered expression of C/EBP family members results in decreased adipogenesis with aging. Am J Physiol Regul Integr Comp Physiol (2001) 1.40
Saliva of the Lyme disease vector, Ixodes dammini, blocks cell activation by a nonprostaglandin E2-dependent mechanism. J Exp Med (1994) 1.39
Reductions in methotrexate and folate influx in methotrexate-resistant lines of Leishmania major are independent of R or H region amplification. J Biol Chem (1987) 1.39
Isolation of virulence genes directing surface glycosyl-phosphatidylinositol synthesis by functional complementation of Leishmania. Proc Natl Acad Sci U S A (1993) 1.36
Potential contribution of maternal zinc supplementation during pregnancy to maternal and child survival. Am J Clin Nutr (1998) 1.33
Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leishmania braziliensis in BALB/c mice. Infect Immun (1996) 1.32
Biochemistry and regulation of folate and methotrexate transport in Leishmania major. J Biol Chem (1987) 1.31
Cloning of Leishmania nucleoside transporter genes by rescue of a transport-deficient mutant. Proc Natl Acad Sci U S A (1998) 1.30
Rapid spontaneous dihydrofolate reductase gene amplification shown by fluorescence-activated cell sorting. Proc Natl Acad Sci U S A (1983) 1.30
Saliva of Lutzomyia longipalpis sibling species differs in its composition and capacity to enhance leishmaniasis. Philos Trans R Soc Lond B Biol Sci (1994) 1.29
Sand fly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production. J Immunol (1995) 1.28
Multiple drug resistance and conservative amplification of the H region in Leishmania major. J Biol Chem (1989) 1.28
Genomewide insertional mutagenesis in Streptomyces coelicolor reveals additional genes involved in morphological differentiation. Proc Natl Acad Sci U S A (2000) 1.28
Discrimination amongst Leishmania by polymerase chain reaction and hybridization with small subunit ribosomal DNA derived oligonucleotides. J Eukaryot Microbiol (1994) 1.27
Pteridine reductase mechanism correlates pterin metabolism with drug resistance in trypanosomatid parasites. Nat Struct Biol (2001) 1.27
Two more independent selectable markers for stable transfection of Leishmania. Mol Biochem Parasitol (1993) 1.25
Nucleotide sequence and hormonal regulation of mouse glycerophosphate dehydrogenase mRNA during adipocyte and muscle cell differentiation. J Biol Chem (1987) 1.25
Amplified DNAs in laboratory stocks of Leishmania tarentolae: extrachromosomal circles structurally and functionally similar to the inverted-H-region amplification of methotrexate-resistant Leishmania major. Mol Cell Biol (1988) 1.25
Shuttle cosmid vectors for the trypanosomatid parasite Leishmania. Gene (1993) 1.24
Identification of an IL-2 binding protein in the saliva of the Lyme disease vector tick, Ixodes scapularis. J Immunol (2001) 1.21
Variation in the salivary peptide, maxadilan, from species in the Lutzomyia longipalpis complex. Insect Mol Biol (1999) 1.19
Salivary gland material from the sand fly Lutzomyia longipalpis has an inhibitory effect on macrophage function in vitro. Parasite Immunol (1993) 1.19
Peptides encoded by the calcitonin gene inhibit macrophage function. J Immunol (1989) 1.19
In vitro activity of sulfonamides and sulfones against Leishmania major promastigotes. Antimicrob Agents Chemother (1987) 1.18
Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major. J Immunol (1998) 1.18
Ancient origin for Hawaiian Drosophilinae inferred from protein comparisons. Proc Natl Acad Sci U S A (1985) 1.17
Sequence and S1 nuclease mapping of the 5' region of the dihydrofolate reductase-thymidylate synthase gene of Leishmania major. Nucleic Acids Res (1987) 1.17
Blockade of CD86 ameliorates Leishmania major infection by down-regulating the Th2 response. J Infect Dis (1996) 1.14
Variants with reduced virulence derived from Leishmania major after mutagen treatment. Parasite Immunol (1987) 1.12
Analysis of the immune responses of mice to infection with Leishmania braziliensis. Infect Immun (1998) 1.11
Leishmania major-parasitized macrophages augment Th2-type T cell activation. J Immunol (1994) 1.11
Borrelia burgdorferi-pulsed dendritic cells induce a protective immune response against tick-transmitted spirochetes. Infect Immun (1997) 1.11
A simple and effective method to assess murine delayed type hypersensitivity to proteins. J Immunol Methods (1981) 1.11
Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo. Infect Immun (1991) 1.10
Stable DNA transfection of a wide range of trypanosomatids. Mol Biochem Parasitol (1991) 1.10
The Leishmania GDP-mannose transporter is an autonomous, multi-specific, hexameric complex of LPG2 subunits. Biochemistry (2000) 1.09
Selection against the dihydrofolate reductase-thymidylate synthase (DHFR-TS) locus as a probe of genetic alterations in Leishmania major. Mol Cell Biol (1996) 1.08
Synthesis and pharmacological investigation of novel 4-(2-methylphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H(1)-antihistaminic agents. Eur J Med Chem (2007) 1.08
Structural alterations of chromosome 2 in Leishmania major as evidence for diploidy, including spontaneous amplification of the mini-exon array. Mol Biochem Parasitol (1989) 1.07
Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni. Parasite Immunol (2009) 1.06